EPIRUS Biopharmaceuticals, Inc. Long-Term Debt, Maturity, Year Two
EPIRUS Biopharmaceuticals, Inc. had Long-Term Debt, Maturity, Year Two of $1.85 million as of 2014-12-31, per its 10-K filed 2015-03-31.
Discontinued › Notes › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2015-03-31
- 2014-12-31: Long-Term Debt, Maturity, Year Two $1.85M.
- 2012-12-31: Long-Term Debt, Maturity, Year Two $6.71M.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2014-12-31 | $1.85M 10-K · filed 2015-03-31 |
| 2012-12-31 | $6.71M 10-K · filed 2013-03-07 |